Platelet-Derived Extracellular Vesicles for Hemostasis and Bleeding Reduction in TBI – Every Labs
Every Labs shared a post on LinkedIn about a recent article by Alpa Trivedi et al., pubished in Journal of Translational Medicine, adding:
“Freeze-dried platelet vesicles cut bleeding in the injured brain, no cold chain needed.
New in the Journal of Translational Medicine (July 20, 2026), a UCSF-led team tested freeze-dried platelet-derived extracellular vesicles (LPEVs) in traumatic brain injury. Mice received one dose 40 minutes after controlled cortical impact.
Why this matters
- Hemorrhage is the leading cause of preventable death worldwide; intracranial bleeding drives early deaths after TBI.
- TBI is the top cause of death and disability in people aged 1 to 44 globally.
- Freeze-dried vesicles need no cold chain, so they could ride in an ambulance or field kit.
Key takeaways
- One LPEV dose 40 minutes post-injury significantly reduced intracranial hemorrhage in a mouse cortical impact model.
- LPEVs generated thrombin and sped clot formation in blood from healthy donors, trauma patients, and dysfunctional platelets.
- Effects ran through GPIIb/IIIa-dependent platelet aggregation; blood-brain barrier permeability and neuroinflammation were unchanged.
Reality check
The authors note LPEVs kept platelets’ hemostatic cargo but lost vasculoprotective factors, decoupling bleeding control from barrier protection. Human trials and dosing studies come next.
Bottom line
A shelf-stable vesicle product may stop brain bleeding early after trauma, though barrier repair will need something more.
Institutions
- University of California, San Francisco
- Cellphire Therapeutics, Inc.
- Vitalant Research Institute
- Uniformed Services University
Citation
Lyophilized platelet derived extracellular vesicles promote hemostasis and attenuate intracranial hemorrhage following traumatic brain injury
Trivedi et al., Journal of Translational Medicine (2026). Volume and article number not yet indexed at time of writing.”
Title: Lyophilized platelet derived extracellular vesicles promote hemostasis and attenuate intracranial hemorrhage following traumatic brain injury
Authors: Alpa Trivedi, Byron Miyazawa, Alexander T. Fields, Michael Matthews, Lindsay Vivona, Callie Keane, Daniel Potter, Huimin Geng, Haoqian Zhang, Hiroki Taenaka, Serena S. Kwek, Kimberly Herrera-Rodriguez, Brenda Nunez-Garcia, Erika Marques de Menezes, Mark Barry, Alison Nair, Ben Kuhn, Philip J. Norris, Lawrence Fong, Michael M. Fitzpatrick, Martin Schreiber, Lucy Z. Kornblith and Shibani Pati
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 5, 2026, 21:19Vidhi Shukla: Anticoagulant Activity of Ficus Racemosa Bark Extract in Rats
-
Aug 5, 2026, 20:30Denis Oduor: Patient Blood Management and Systemic Transfusion Reform
-
Aug 5, 2026, 20:15Salih Ehsan: Diagnostic Screening Strategy for Hemoglobinopathy Traits
-
Aug 5, 2026, 19:05Alfonso J. Tafur: Thromboinflammation and Hemostatic Dysfunction as Predictors of Early Pulmonary Embolism Mortality
-
Aug 5, 2026, 19:00Grigoris Gerotziafas: DU T2H 2026–2027 Enrolment Is Now Open
-
Aug 5, 2026, 19:00Konstantin Stark: Now Recruiting for the DFG Collaborative Research Center 1784
-
Aug 5, 2026, 18:59Should Genotype Guide Thromboprophylaxis in Pregnant Women With Antithrombin Deficiency? – RPTH Journal
-
Aug 5, 2026, 18:59Ayisha Munavar: Understanding PNH – A Rare Disease That Demands Early Recognition
-
Aug 5, 2026, 18:58Kalyan Roy: The Oxygen Delivery Paradox in Polycythaemia Vera